IntelGenx Technologies Corp (IGXT)

[BioSpecialist]

The wonder pill that could STOP your brain ageing: Common asthma drug may be a cure for Alzheimer's, claims study

http://www.dailymail.co.uk/sciencetech/article-3290482/The-wonder-pill-STOP-ageing-Common-asthma-drug-cure-Alzheimer-s-claims-study.html


The Drug Montelukast mentioned above in the article alone is worth multiple times the current market cap of laughable $46 Million .If everything goes well with the potential Blockbuster Drug then IGXT will be the next Billion Dollar Company .

IntelGenx to Initiate Phase 1 Trial of Montelukast
http://www.intelgenx.com/investors/press-releases/press-release-details/2016/IntelGenx-to-Initiate-Phase-1-Trial-of-Montelukast/default.aspx

IntelGenx expects results from the phase 1 trial to be available in September 2016. Following the completion of the phase 1 results, the Company will begin preparation work to initiate a phase 2 study where patients will be enrolled. IntelGenx will be actively seeking a partnership or alliance opportunity to complete the remaining developmental work and commercialization of this product.

"Montelukast is by far the most important and promising drug repurposing opportunity that the company has in its product pipeline," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "IntelGenx with Dr. Aigner, is taking a leadership position in this most serious unmet need affecting millions globally. The market for degenerative diseases of the brain is a multi-billion-dollar opportunity for the company. We look forward to communicating the results from the phase 1 study and advancing montelukast forward to reach its full potential."